Monitoring for prolonged QT syndrome 7% have an increase from baseline QTc >60 ms; prolonged interval >500 ms is rare (1%); if QTcF >500 ms, interrupt gilteritinib and resume at 80 mg when QTc interval returns to ≤480 ms; substitute QT prolonging with non-QT prolonging coadministered ...